RE: Regional Nodal Irradiation After Breast-Conserving Surgery for Early HER2-Positive Breast Cancer: Results of a Subanalysis From the ALTTO Trial

Affiliations

¹ Department of Radiation Oncology, Henri Mondor University Hospital, AP-HP, and Henri Mondor Breast Cancer Center, INSERM U955 EQ 07, University of Paris-Est Créteil (UPEC), Créteil, France.
² Italian Hospital and Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel.

Comment

Yazid Belkacemi et al. J Natl Cancer Inst. 2018.

. 2018 May 1;110(5):539-540.

doi: 10.1093/jnci/djx241.

¹ Department of Radiation Oncology, Henri Mondor University Hospital, AP-HP, and Henri Mondor Breast Cancer Center, INSERM U955 EQ 07, University of Paris-Est Créteil (UPEC), Créteil, France.
² Italian Hospital and Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel.

No abstract available

Comment in

Response.
Gingras I, Azim HA Jr. Gingras I, et al. J Natl Cancer Inst. 2018 May 1;110(5):541. doi: 10.1093/jnci/djx242. J Natl Cancer Inst. 2018. PMID: 29177472 No abstract available.

Regional Nodal Irradiation After Breast Conserving Surgery for Early HER2-Positive Breast Cancer: Results of a Subanalysis From the ALTTO Trial.
Gingras I, Holmes E, De Azambuja E, Nguyen DH, Izquierdo M, Anne Zujewski J, Inbar M, Naume B, Tomasello G, Gralow JR, Wolff AC, Harris L, Gnant M, Moreno-Aspitia A, Piccart MJ, Azim HA Jr. Gingras I, et al. J Natl Cancer Inst. 2017 Aug 1;109(8):djw331. doi: 10.1093/jnci/djw331. J Natl Cancer Inst. 2017. PMID: 28376188 Free PMC article. Clinical Trial.